The Zanos Laboratory at the University of Cyprus has recently been featured in one of Cyprus’ leading newspapers for its groundbreaking BioNic research program. Led by Principal Investigator Dr. Panos Zanos and Marie Curie fellow Dr. Andrea N. Georgiou, this innovative study aims to revolutionize smoking cessation strategies by identifying biological markers that can predict vulnerability to relapse in individuals attempting to quit smoking.
The BioNic program combines cutting-edge biological research with a clinically-tested avatar-based psychological intervention. By analyzing various biomarkers such as stress hormones, neurotransmitters, and epigenetic indicators associated with addiction, the research team is working towards developing more personalized and effective approaches to smoking cessation. This scientific endeavor not only promises to enhance our understanding of the biological mechanisms underlying nicotine addiction and relapse but also holds the potential to significantly improve success rates for those striving to quit smoking. The feature in the national newspaper underscores the importance and potential impact of this research on public health in Cyprus and beyond.